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osting by EAbstract Objective: To assess gender-related differences in the presentation, management, and
in-hospital outcomes among acute coronary syndrome (ACS) patients from Oman.
Methods: Data were analyzed from 1579 consecutive ACS patients from Oman duringMay 8, 2006
to June 6, 2006 and January 29, 2007 to June 29, 2007, as part of Gulf RACE (Registry of Acute
Coronary Events). Analyses were conducted using univariate and multivariate statistical techniques.
Results: In this study, 608 (39%) patients were women with mean age 62 ± 12 vs. 57 ± 13 years
(p< 0.001). More women were seen in the older age groups (age <55 years: 25% vs. 43%,
55–74 years: 60% vs. 49% and >75 years: 15% vs. 8%; p< 0.001). Women had higher frequencies
of diabetes, hypertension, hyperlipidemia, obesity, angina, and aspirin use, but less history of smok-
ing. Women were signiﬁcantly less likely to have ischemic chest pain, ST-elevation myocardial infarc-
tion (STEMI), non-STEMI and were more likely to have dyspnea, unstable angina, ST depression
and left bundle branch block. Both groups received ACS medications and cardiac catheterization
equally; however, women received anticoagulants (88% vs. 79%; p< 0.001), angiotensin-convertingartment of Cardiology, Royal
Oman. Tel.: +968 92603746;
o.co.in (P. Panduranga).
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Saud University.
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18 K. Sulaiman et al.enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) (70% vs. 65%; p= 0.050)
more and clopidogrel less (20% vs. 29%; p< 0.001). Women experienced more recurrent ischemia
and heart failure but with similar in-hospital mortality (4.6% vs. 4.3%) even after adjusting for age
(p= 0.500).
Conclusions: Women admitted with ACS were older than men, had more risk factors, presented dif-
ferently with no difference in hospital mortality. This is similar to Gulf RACE study except for mor-
tality. Women received anticoagulants/ACEIs /ARBs more but were under-treated with clopidogrel.
ª 2010 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Observational studies have shown that guideline-recommended
management strategies in acute coronary syndrome (ACS) are
used less frequently in women when compared to men (Vaccari-
no et al., 2005; Radovanovic et al., 2007; El-Menyar and Al
Suwaidi, 2009). ACS studies have shown that females have a
higher mortality rate than males (Aguado-Romeo et al., 2007;
El-Menyar et al., 2009). The Gulf Registry of Acute Coronary
Events (Gulf RACE) (El-Menyar et al., 2009) and Global Reg-
istry of Acute Coronary Events (GRACE) (Dey et al., 2009)
have revealed that adverse outcomes in women are signiﬁcantly
higher when compared to men.
In contrast to above reports, there are studies demonstrating
no gender differences in the management and mortality among
ACS patients (Hochman et al., 1997; Perers et al., 2005). Thus,
the effect of gender on the outcome in patients with ACS is con-
troversial. Although, Gulf RACE reported signiﬁcant gender
bias in ACS patients from six Gulf countries (including Oman),
we wanted to evaluate whether this bias exists speciﬁcally in
Oman, as well as compare our results with those of Gulf RACE
and GRACE. The aim of this study was to assess gender-
related differences in the presentation, management, and in-
hospital outcomes among ACS patients from Oman.
2. Methods
We retrospectively analyzed data from 1579 consecutive pa-
tients from Oman enrolled in a prospective ACS registry from
the Middle East [Gulf RACE (Registry of Acute Coronary
Events)]. Gulf RACE was a prospective, multinational multi-
centre registry of consecutive patients above 18 years of age
hospitalized with the ﬁnal diagnosis of ACS (Unstable angina,
non-ST-elevation and ST-elevation myocardial infarction)
from various hospitals in six Middle Eastern countries. There
were no exclusion criteria. Recruitment in the pilot phase
started from May 8, 2006 to June 6, 2006. Enrollment in the
next phase of the registry started on January 29, 2007 and con-
tinued for 5 months till June 29, 2007. The present study in-
cluded patients from the registry admitted to 15 hospitals in
Oman during this period. Methods of multinational Gulf
RACE have already been described previously (Zubaid et al.,
2008). Demographic and other baseline clinical characteristics
of the patients along with in-hospital management were evalu-
ated. Diabetes was deﬁned as having a history of diabetes diag-
nosed and/or treated with medication and/or diet or fasting
blood glucose 7.0 mmol/L (126 mg/dL) or greater. Hyperten-
sion was deﬁned as having a history of hypertension diagnosed
and/or treated with medication, diet, and/or exercise, blood
pressure greater than 140 mmHg systolic or 90 mmHg diastolicon at least two occasions or as receiving any antihypertensive
drug. Hyperlipidemia was deﬁned as history of dyslipidemia
diagnosed and/or treated by a physician or total cholesterol
greater than 5.18 mmol/L (200 mg/dL), low-density lipopro-
tein greater than or equal to 3.37 mmol/L (130 mg/dL), or
high-density lipoprotein less than 1.04 mmol/L (40 mg/dL).
Current smoker was deﬁned as a person smoking cigarettes
within one month of index admission. A positive family history
for coronary artery disease was deﬁned as evidence of coro-
nary artery disease in a parent, sibling, or children before
55 years of age. Obesity was deﬁned as body mass index
(BMI) greater than 25 kg/m2.
Diagnosis of the different types of ACS and deﬁnitions of
data variables and outcome parameters were based on the
American College of Cardiology clinical data standards (Can-
non et al., 2001). Outcome parameters evaluated during the
hospital stay included in-hospital mortality, recurrent ische-
mia/re-infarction, heart failure, cardiogenic shock, major
bleed, stroke and ventilator requirement. Institutional review
board approval was obtained.
2.1. Statistical analysis
Descriptive statistics were used to describe the data. For cate-
gorical variables, frequencies and percentages were reported.
Differences between groups were analyzed using Pearson’s v2
tests (or Fisher’s exact tests for cells less than 5). For continu-
ous variables, means and standard deviations were presented
and analyses were conducted using Student’s t-test. To obtain
age- and gender- adjusted in-hospital mortality, the analysis
was performed using multivariable logistic regression and the
results were presented as odds ratio (OR) with the associated
95% conﬁdence interval. An a priori two-tailed level of signif-
icance was set at the 0.05 level. Statistical analyses were con-
ducted using STATA version 10.1 (STATA Corporation,
College Station, TX).
3. Results
A total of 1579 patients admitted with ACS were enrolled in
the study. Table 1 shows the demographic and baseline clinical
characteristics of the patients. In this study, 608 (39%) of the
patients were women with mean age 62 vs. 57 years in women
and men, respectively (p< 0.001). Among 1341 (85%) Omani
nationals, women were older than men (62 vs. 60 years;
p< 0.001). As the age increased, more women were seen in
the older age groups when compared to men (age <55 years:
25% vs. 43%, 55–74 years: 60% vs. 49% and >75 years:
15% vs. 8%; p< 0.001). Women had higher frequencies of
diabetes (43% vs. 33%; p< 0.001), hypertension (66% vs.
Table 1 Baseline clinical characteristics of women and men presenting with acute coronary syndrome.
Characteristics Women (n= 608) Men (n= 971) P-value
Age, mean ± SD, years 62 ± 12 57 ± 13 <.001
Diabetes mellitus 261(43) 320 (33) <.001
Hypertension 401 (66) 437 (45) <.001
Hyperlipidemia 249 (41) 301 (31) <.001
Current smoker 06 (1.0) 272 (28) <.001
Body mass index, mean ± SD, kg/m2 28 ± 6 26 ± 4 <.001
Family history of CAD 36 (5.9) 85 (8.7) .041
Prior angina 340 (56) 417 (43) <.001
Past MI 91 (15) 194 (20) .019
Past PCI 50 (8.2) 68 (7.0) NS
Past CABG 39 (6.4) 69 (7.1) NS
Aspirin use 334 (55) 417 (43) <.001
COPD 34 (5.6) 43 (4.4) NS
Stroke 26 (4.3) 29 (3.0) NS
Dialysis 13 (2.1) 13 (1.4) NS
PVD 14 (2.3) 20 (2.1) NS
Ischemic chest pain 407 (67) 747 (77) <.001
Atypical chest pain 49 (8.1) 60 (6.2) NS
Dyspnea 109 (18) 107 (11) <.001
ST elevation 73 (12) 320 (33) <.001
ST depression 249 (41) 281 (29) <.001
LBBB 39 (6.4) 33 (3.4) .005
Other 231 (38) 291 (30) .002
Normal 19 (3.1) 37 (3.8) NS
Unstable angina 407 (67) 388 (40) <.001
Non-STEMI 127 (21) 262 (27) .010
STEMI 73 (12) 320 (33) <.001
LBBB MI 02 (0.3) 08 (0.8) NS
NS = non-signiﬁcant; SD = standard deviation; CAD= coronary artery disease; MI = myocardial infarction;
PCI = percutaneous coronary intervention; CABG= coronary artery bypass surgery; COPD= chronic obstructive
pulmonary disease; PVD= peripheral vascular disease; LBBB= left bundle branch block; and STEMI = ST-ele-
vation myocardial infarction; and Percents are column percentages. All values are n (%) unless speciﬁed otherwise.
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Figure 1 In-hospital management of women and men with acute
coronary syndrome. ASA = aspirin; CLO = clopidogrel;
HEP = heparin (includes low molecular weight heparin);
GP = glycoprotein IIb/IIIa inhibitors; BB = beta-blockers;
ACE = angiotensin-converting enzyme inhibitors; ARB = angio-
tensin II receptor blockers; STA= statins; and CAG= coronary
angiography. Analyses were conducted using Student’s t-test,
Pearson’s v2 test, or Fisher’s exact test, whenever appropriate.
*Signiﬁcant p-value of <0.05.
Gender-related differences in the presentation, management, and outcomes 1945%; p< 0.001), hyperlipidemia (41% vs. 31%; p< 0.001),
pre-existing angina (56% vs. 43%; p< 0.001), and aspirin
use (55% vs. 43%; p< 0.001), but less often had history of
smoking (1.0% vs. 28%; p< 0.001) and past myocardial
infarction (15% vs. 20%; p= 0.019).
When compared to men women were less likely to present
with ischemic chest pain (67% vs. 77%; p< 0.001), ST-eleva-
tion myocardial infarction (STEMI) (12% vs. 33%; p< 0.001)
and non-STEMI (21% vs. 27%; p= 0.010). They were more
likely to present with dyspnea (18% vs. 11%; p< 0.001) and
unstable angina (67% vs. 40%; p< 0.001). With regard to
atypical chest pain, no signiﬁcant differences were noted be-
tween the groups (8.1% vs. 6.2%). ST depression was more
common in women patients when compared to men (41%
vs. 29%; p< 0.001), who had more of ST elevation (33%
vs. 12%; p< 0.001). Left bundle branch block was seen more
common in women (6.4% vs. 3.4%; p= 0.005).
Fig. 1 shows in-hospital management of the cohort. Both
groups received in-hospital aspirin, statin, beta-blockers,
thrombolytic therapy, glycoprotein (GP) IIb/IIIa inhibitors
and in-hospital cardiac catheterization equally; however, wo-
men patients were more likely to be treated with anticoagu-
lants (88% vs. 79%; p< 0.001) and angiotensin-converting
enzyme inhibitors (ACEIs) or angiotensin II receptor blockers
(ARBs) (70% vs. 65%; p= 0.050) and less likely to be treated
with clopidogrel (20% vs. 29%; p< 0.001). At discharge, both
groups received aspirin (93% vs. 95%), statin (83% vs. 86%),ACEIs or ARBs (71% vs. 71%) equally but were less likely to
be discharged on clopidogrel (17% vs. 25%; p< 0.001) or
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Figure 2 Missed opportunities for thrombolysis in women and
men with acute coronary syndrome. *Signiﬁcant p-value of 6.05.
Table 2 In-hospital outcome in women and men presenting
with acute coronary syndrome.
Characteristic Women
(n= 608)
Men
(n= 971)
p-Value
Recurrent ischemia 73 (12) 77 (8.0) .024
Re-infarction 10 (1.7) 28 (2.9) NS
Congestive heart failure 170 (28) 233 (24) .049
Ventilation 37 (6.1) 45 (4.7) NS
Cardiogenic shock 34 (5.6) 55 (5.7) NS
Major bleed 04 (0.7) 12 (1.3) NS
Stroke 05 (0.8) 11 (1.1) NS
Mortality 28 (4.6) 41 (4.3) NS
NS = non-signiﬁcant and percents are column percentages. All
values are n (%).
20 K. Sulaiman et al.beta-blockers (66% vs. 71%; p= 0.019). Fig. 2 shows missed
opportunities for thrombolysis in women and men with acute
coronary syndrome. When compared to men, women pre-
sented late (>12 h) after chest pain (21% vs. 32%;
p= 0.050), but there were no differences in the use of throm-
bolysis when indicated.
Table 2 shows the complications encountered by the pa-
tients. Women patients experienced more recurrent ischemia
(12% vs. 8%; p= 0.024) and heart failure (28% vs. 24%;
p= 0.049). In-hospital mortality was 4.6% and 4.3% in wo-
men and men, respectively, with no signiﬁcant difference.
When adjusted for age, gender status was still not an indepen-
dent predictor of in-hospital mortality in ACS patients (ad-
justed odds ratio 1.17; 95% conﬁdence interval 0.70–1.93;
p= 0.500).
4. Discussion
In this study, 39% of patients with ACS in Oman were women.
Women presenting with ACS were older than men and had
higher rates of cardiovascular risk factors (diabetes mellitus,
hypertension, hyperlipidemia, obesity) and a lower rate of
smoking than of men. This is similar to Gulf RACE and
GRACE studies (El-Menyar et al., 2009; Dey et al., 2009). This
study conﬁrmed that female ACS patients have different clin-
ical characteristics. It is known that women are more likelythan men to have unstable angina and less likely to present
with myocardial infarction (Akhter et al., 2009). Moreover,
women patients with ACS are less likely to present with ische-
mic chest pain (El-Menyar et al., 2009; Dey et al., 2009,). All
these were conﬁrmed in this study.
Several studies have demonstrated that female gender is an
independent predictor of adverse outcomes (Vaccarino et al.,
2005; Radovanovic et al., 2007; Aguado-Romeo et al., 2007;
El-Menyar and Al Suwaidi, 2009; El-Menyar et al., 2009;
Dey et al., 2009). Our analysis demonstrated that women expe-
rienced more recurrent ischemia and heart failure. The reason
for these complications in women is unclear, but may relate to
the poorer myocardial reserve in women suggested by diastolic
dysfunction and reduced collateral blood ﬂow (Hochman
et al., 1997).
Some studies have reported that acute and discharge guide-
line-recommended medical treatment as well as invasive treat-
ment was consistently used less often in women (Blomkalns
et al., 2005; Heer et al., 2006; Hvelplund et al., 2010). In the
Gulf RACE study, compared to men, women were signiﬁ-
cantly less treated with beta blockers and antiplatelet therapy,
whereas reperfusion therapy was non-signiﬁcantly less used in
women. In a study (Moriel et al., 2008), with similar cardiovas-
cular risk proﬁle, there was relative under-utilization of acute
reperfusion, less women than men received GP IIb/IIIa-inhib-
itors, and at discharge, less women received clopidogrel, ACE-
Is or ARBs with no difference in mortality. In the CRUSADE
analysis (Blomkalns et al., 2005), women were less likely to re-
ceive acute heparin. In this study, women were treated as
aggressively as men in terms of use of medications like aspirin,
statin, beta blockers, GP IIb/IIIa-inhibitors, thrombolytic
therapy and coronary angiography. On the contrary, they were
more aggressively treated with heparins & ACEIs or ARBs.
However, women were under treated with clopidogrel as in
the previous studies (Heer et al., 2006; Moriel et al., 2008).
This shows that there are signiﬁcant gender differences in the
pharmacological treatment of ACS patients in Oman.
ACS studies have shown that females have a higher mortal-
ity rate than males (Aguado-Romeo et al., 2007; El-Menyar
et al., 2009). When compared to Gulf RACE study, we did
not have gender related mortality difference which is similar
to few other published studies (Dey et al., 2009; Hochman
et al., 1997; Perers et al., 2005). This could be due to the signif-
icant differences in the treatment of female patients with ACS
in Oman, compared to other Gulf countries. Women admitted
with ACS in Oman received all guideline-recommended medi-
cations, speciﬁcally; they were more aggressively treated with
heparins & ACEIs or ARBs. This appropriate treatment was
lacking among women patients in the Gulf RACE. In a large
Western study (Anand et al., 2005), there was no mortality dif-
ference between men and women, but women had a higher rate
of recurrent ischemia than men as seen in our study. In a recent
meta-analysis, in STEMI, 30-day mortality was higher among
women whereas in non-STEMI and unstable angina, mortality
was lower among women. Women more often had non-
obstructive and less often had 2-vessel and 3-vessel coronary
disease, for any type of ACS and the relationship between
sex and 30-day mortality was similar across the levels of angio-
graphic disease severity (Berger et al., 2009). They concluded
that sex-based differences in patients with ACS were largely
explained by associated risk factors, clinical differences at pre-
sentation and severity of angiographically documented disease.
Gender-related differences in the presentation, management, and outcomes 21This was also noted in our study except that we did not valuate
the angiographic results, as patients undergoing catheteriza-
tion were too small in number.5. Conclusions
Women admitted with ACS were older than men, had more
risk factors, presented differently with no difference in hospital
mortality. This is similar to Gulf RACE study except for mor-
tality, which was similar among men and women presenting
with ACS in Oman. Women received anticoagulants/ACEIs/
ARBs more but were under-treated with clopidogrel. Reasons
for the signiﬁcant gender differences in the pharmacological
management of ACS patients in Oman need to be investigated
further.
5.1. Limitations of the study
The major limitation of our study is its observational and ret-
rospective analysis of a prospective registry and the possible
confounding variables not controlled in the study.
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